Z-0266-2023Class II
InControl Insulin Syringes, Short Needle, 29 Gauge, 1CC
Allison Medical, Inc. / initiated 2018-01-19 / Completed / root cause: labeling and UDI
Allison Medical, Inc. began a recall of InControl Insulin Syringes, Short Needle, 29 Gauge, 1CC on . FDA classified it as Class II and gives the reason as "Insulin syringe retail packages incorrectly labeled as "Short Needle"". As of , the recall status on record is Completed, and MDM tags the root cause as labeling and UDI.
Recall record
- Recall number
- Z-0266-2023
- Classification
- Class II
- Status
- Completed
- Initiated
- Posted
- Recalling firm
- Allison Medical, Inc.
- Product
- InControl Insulin Syringes, Short Needle, 29 Gauge, 1CC
- Product code
- FMF Syringe, Piston
- Reason for recall
- Insulin syringe retail packages incorrectly labeled as "Short Needle".
- Root cause tag
- labeling and UDI
- FDA root cause
- Error in labeling
- Action
- On 01/19/2018, The recalling firm notified their customer of the recall.
- Quantity in commerce
- 1,500 Boxes (150,000 syringes)
- Distribution
- Texas
- Product codes and lots
- UDI/Lot/Expiration: 00041220791484/ 170407/ 2022-03-31
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0266-2023 | Class II | Completed | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
